Rebecca Holdren, MD
Physical Medicine & Rehabilitation · Greenville, SCNPI 1245217322
Payments from drug & device makers
What this record shows
This record is dominated by other: $12,864 of the $15,366 with a category attached, or 83.7%. International Rehabilitative Sciences, Inc accounts for 83.9% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $13,719, more than ten times the $471 reported in 2019. Among physical medicine & rehabilitation clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $140.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$13K
- Averitas Pharma Inc.$339
- Medtronic$265
- AbbVie$259
- Forte Bio-pharma LLC$205
- Collegium Pharmaceutical, Inc.$183
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,50216%
- Other$12,86484%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Rehabilitative Sciences, Inc | 2 | $12,887 |
| Averitas Pharma Inc. | 14 | $339 |
| Medtronic(2 entities) | 7 | $265 |
| AbbVie(2 entities) | 15 | $259 |
| Forte Bio-pharma LLC | 11 | $205 |
| Collegium Pharmaceutical, Inc. | 8 | $183 |
| Boston Scientific | 3 | $180 |
| Scilex Pharmaceuticals Inc. | 8 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $153 |
| Globus Medical(2 entities) | 2 | $128 |
| GRT US Holding, Inc. | 1 | $120 |
| SPR Therapeutics, Inc | 4 | $85 |
| Valinor Pharma, LLC | 3 | $51 |
| Nevro Corp. | 3 | $44 |
| Vertex | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 3 | $36 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Assertio Therapeutics, Inc. | 2 | $29 |
| Novartis | 2 | $24 |
| Radius Health, Inc. | 1 | $23 |
| Tonix Medicines, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Saol Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RS-4i Plus with Intersperse$12,864
- RS-LBG, RS-FBG, RS-SG$12,864
- VANTA ADAPTIVESTIM$162
- SPECTRA WAVEWRITER$125
- Qutenza$120
- XLIF$113
How this compares
$15,366 in reported general payments places this provider in the 95th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
See all physical medicine & rehabilitation providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 68 | $231,227 |
| BelbucaBuprenorphine Hcl | 253 | $205,190 |
| Buprenorphine | 307 | $73,758 |
| Nucynta ErTapentadol Hcl | 35 | $45,674 |
| MovantikNaloxegol Oxalate | 67 | $34,979 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,311 | $26,943 |
| NucyntaTapentadol Hcl | 27 | $26,247 |
| Xtampza ErOxycodone Myristate | 26 | $15,984 |
| Nurtec OdtRimegepant Sulfate | 14 | $13,754 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 352 | $10,954 |
| BelsomraSuvorexant | 15 | $10,614 |
| Ajovy SyringeFremanezumab-Vfrm | 13 | $9,243 |
| Gabapentin | 551 | $8,798 |
| Pregabalin | 544 | $8,620 |
| Lidocaine | 97 | $8,117 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Nucynta, Xtampza Er | $183 | $293,094341 claims |
| GRT US Holding, Inc.Qutenza | $120 | $231,22768 claims |
| AbbVieLinzess | $259 | $6,60711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
Other physical medicine & rehabilitation in Greenville
- Eleasa HulonGreenville$10K
- Robert LeblondGreenville$3K
- Jennifer MartinGreenville$3K
- Vanessa RoosGreenville$2K
- Jyoti MathGreenville$1K
- Robert SchwartzGreenville$526
- Lynwood HollisGreenville$329
- Melissa RichardsonGreenville$318
- Krystal YankowskiGreenville$214
- William LorenzFlorence$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.